Abstract:Although effective, chemotherapy can inadvertently induce tumor immunosuppression, leading to undesired immunotherapeutic outcomes. Chemo‐immunotherapy has emerged as an innovative approach to reverse the immunosuppressive tumor microenvironment (ITME) and enhance immune responses. This review discusses the recent strategies of chemo‐immunotherapy to surmount the ITME, emphasizing the usage of functional nanomaterials for ITME modulation, and offering new perspectives on improving cancer chemo‐immunotherapy. Chemotherapy is a critical modality in cancer therapy to combat malignant cell proliferation by directly attacking cancer cells and inducing immunogenic cell death, serving as a vital component of multi‐modal treatment strategies for enhanced therapeutic outcomes. However, chemotherapy may inadvertently contribute to the immunosuppression of the tumor microenvironment (TME), inducing the suppression of antitumor immune responses, which can ultimately affect therapeutic efficacy. Chemo‐immunotherapy, combining chemotherapy and immunotherapy in cancer treatment, has emerged as a ground‐breaking approach to target and eliminate malignant tumors and revolutionize the treatment landscape, offering promising, durable responses for various malignancies. Notably, functional nanomaterials have substantially contributed to chemo‐immunotherapy by co‐delivering chemo‐immunotherapeutic agents and modulating TME. In this review, recent advancements in chemo‐immunotherapy are thus summarized to enhance treatment effectiveness, achieved by reversing the immunosuppressive TME (ITME) through the exploitation of immunotherapeutic drugs, or immunoregulatory nanomaterials. The effects of two‐way immunomodulation and the causes of immunoaugmentation and suppression during chemotherapy are illustrated. The current strategies of chemo‐immunotherapy to surmount the ITME and the functional materials to target and regulate the ITME are discussed and compared. The perspective on tumor immunosuppression reversal strategy is finally proposed.

Application Prospect of Metal Complexes in Chemoimmunotherapy of Tumors

Development of Platinum Complexes for Tumor Chemoimmunotherapy

Recent advances in the development of metallodrugs for cancer chemoimmunotherapy

Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy

Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy

Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy

Recent Advances of Platinum-Based Anticancer Complexes in Combinational Multimodal Therapy

Towards the Rational Design of Platinum(ii) and Gold(iii) Complexes As Antitumour Agents

Metal ions and nanometallic materials in antitumor immunity: Function, application, and perspective

Engineered Metal and Their Complexes for Nanomedicine-Elicited Cancer Immunotherapy

Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics

Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials

Recent Researches in Metal Supramolecular Complexes As Anticancer Agents.

Review: Recent Advances and Future Development of Metal Complexes As Anticancer Agents

Biological Effects of Metal-Based Nanomaterials for Tumor Metalloimmunotherapy

Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses.

Research progress of natural product-conjugated platinum and gold complexes as potential antitumor agents

New Strategies and Trends for the Design of Metal-Based Anticancer Drugs

Immunomodulatory metal-based biomaterials for cancer immunotherapy

Recent Progress in Ferroptosis Induced Tumor Cell Death by Anti-tumor Metallic Complexes.

Metal Complexes Induced Ferroptosis for Anticancer Therapy